Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Occurrence of respiratory symptoms in persons with restrictive ventilatory impairment compared with persons with chronic obstructive pulmonary disease: The PLATINO study.

Nonato NL, Nascimento OA, Padilla RP, de Oca MM, Tálamo C, Valdivia G, Lisboa C, López MV, Celli B, Menezes AM, Jardim JR.

Chron Respir Dis. 2015 Aug;12(3):264-73. doi: 10.1177/1479972315588004. Epub 2015 Jun 3.

PMID:
26041119
2.

Assessment of five different guideline indication criteria for spirometry, including modified GOLD criteria, in order to detect COPD: data from 5,315 subjects in the PLATINO study.

Luize AP, Menezes AM, Perez-Padilla R, Muiño A, López MV, Valdivia G, Lisboa C, Montes de Oca M, Tálamo C, Celli B, Nascimento OA, Gazzotti MR, Jardim JR; PLATINO Team.

NPJ Prim Care Respir Med. 2014 Oct 30;24:14075. doi: 10.1038/npjpcrm.2014.75.

3.

FEV1 is a better predictor of mortality than FVC: the PLATINO cohort study.

Menezes AM, Pérez-Padilla R, Wehrmeister FC, Lopez-Varela MV, Muiño A, Valdivia G, Lisboa C, Jardim JR, de Oca MM, Talamo C, Bielemann R, Gazzotti M, Laurenti R, Celli B, Victora CG; PLATINO team.

PLoS One. 2014 Oct 6;9(10):e109732. doi: 10.1371/journal.pone.0109732. eCollection 2014.

4.

A population-based cohort study on chronic obstructive pulmonary disease in Latin America: methods and preliminary results. The PLATINO Study Phase II.

Menezes AM, Muiño A, López-Varela MV, Valdivia G, Lisboa C, Jardim JR, Montes de Oca M, Tálamo C, Wehrmeister FC, Perez-Padilla R; Equipo del estudio Platino.

Arch Bronconeumol. 2014 Jan;50(1):10-7. doi: 10.1016/j.arbres.2013.07.014. Epub 2013 Dec 12. English, Spanish.

5.

Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma.

Menezes AMB, Montes de Oca M, Pérez-Padilla R, Nadeau G, Wehrmeister FC, Lopez-Varela MV, Muiño A, Jardim JRB, Valdivia G, Tálamo C; PLATINO Team.

Chest. 2014 Feb;145(2):297-304. doi: 10.1378/chest.13-0622.

PMID:
24114498
6.

Reliability of FEV1/FEV6 to diagnose airflow obstruction compared with FEV1/FVC: the PLATINO longitudinal study.

Perez-Padilla R, Wehrmeister FC, Celli BR, Lopez-Varela MV, Montes de Oca M, Muiño A, Talamo C, Jardim JR, Valdivia G, Lisboa C, Menezes AM; PLATINO Team.

PLoS One. 2013 Aug 1;8(8):e67960. doi: 10.1371/journal.pone.0067960. Print 2013.

7.

Comorbidities and health status in individuals with and without COPD in five Latin American cities: the PLATINO study.

López Varela MV, Montes de Oca M, Halbert R, Muiño A, Tálamo C, Pérez-Padilla R, Jardim JR, Valdivia G, Pertuzé J, Menezes AM; PLATINO team.

Arch Bronconeumol. 2013 Nov;49(11):468-74. doi: 10.1016/j.arbres.2013.05.003. Epub 2013 Jul 13. English, Spanish.

8.

Perceptions of short and long sleep duration and comorbid conditions: the PLATINO study.

Torre-Bouscoulet L, Garcia Sancho C, Vázquez García JC, Salazar-Peña CM, Lopez Varela MV, de Oca MM, Muiño A, Tálamo C, Valdivia G, Menezes AM, Perez-Padilla R.

Sleep Med. 2013 Sep;14(9):850-7. doi: 10.1016/j.sleep.2013.04.014. Epub 2013 Jul 12.

PMID:
23856294
9.

Beta 2 adrenergic receptor polymorphisms, at codons 16 and 27, and bronchodilator responses in adult Venezuelan asthmatic patients.

Larocca N, Moreno D, Garmendia JV, Velasquez O, Martin-Rojo J, Talamo C, Garcia A, De Sanctis JB.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2013 Dec;157(4):374-8. doi: 10.5507/bp.2012.084. Epub 2012 Nov 2.

10.

Airflow obstruction in never smokers in five Latin American cities: the PLATINO study.

Perez-Padilla R, Fernandez R, Lopez Varela MV, Montes de Oca M, Muiño A, Tálamo C, Brito Jardim JR, Valdivia G, Baptista Menezes AM.

Arch Med Res. 2012 Feb;43(2):159-65. doi: 10.1016/j.arcmed.2012.03.007. Epub 2012 Apr 2.

PMID:
22475778
11.

The chronic bronchitis phenotype in subjects with and without COPD: the PLATINO study.

de Oca MM, Halbert RJ, Lopez MV, Perez-Padilla R, Tálamo C, Moreno D, Muiño A, Jardim JR, Valdivia G, Pertuzé J, Menezes AM.

Eur Respir J. 2012 Jul;40(1):28-36. doi: 10.1183/09031936.00141611. Epub 2012 Jan 26.

12.

Paid employment in subjects with and without chronic obstructive pulmonary disease in five Latin American cities: the PLATINO study.

Montes de Oca M, Halbert RJ, Talamo C, Perez-Padilla R, Lopez MV, Muiño A, Jardim JR, Valdivia G, Pertuzé J, Moreno D, Menezes AM; PLATINO team.

Int J Tuberc Lung Dis. 2011 Sep;15(9):1259-64, i-iii. doi: 10.5588/ijtld.10.0508.

PMID:
21943855
13.

Sex-related differences in COPD in five Latin American cities: the PLATINO study.

Lopez Varela MV, Montes de Oca M, Halbert RJ, Muiño A, Perez-Padilla R, Tálamo C, Jardim JR, Valdivia G, Pertuzé J, Moreno D, Menezes AM; PLATINO Team.

Eur Respir J. 2010 Nov;36(5):1034-41. doi: 10.1183/09031936.00165409. Epub 2010 Apr 8.

14.

Acute bronchodilator responsiveness in subjects with and without airflow obstruction in five Latin American cities: the PLATINO study.

Montes de Oca M, Perez-Padilla R, Tálamo C, Halbert RJ, Moreno D, Lopez MV, Muiño A, José Roberto BJ, Valdivia G, Pertuzé J, Ana Maria BM; PLATINO Team.

Pulm Pharmacol Ther. 2010 Feb;23(1):29-35. doi: 10.1016/j.pupt.2009.09.005. Epub 2009 Oct 8.

PMID:
19818867
15.

Prevalence of smoking and incidence of initiation in the Latin American adult population: the PLATINO study.

Menezes AM, Lopez MV, Hallal PC, Muiño A, Perez-Padilla R, Jardim JR, Valdivia G, Pertuzé J, de Oca MM, Tálamo C, Victora CG; PLATINO Team.

BMC Public Health. 2009 May 22;9:151. doi: 10.1186/1471-2458-9-151.

16.

Health status perception and airflow obstruction in five Latin American cities: the PLATINO study.

Montes de Oca M, Tálamo C, Halbert RJ, Perez-Padilla R, Lopez MV, Muiño A, Jardim JR, Valdivia G, Pertuzé J, Moreno D, Menezes AM; PLATINO Team.

Respir Med. 2009 Sep;103(9):1376-82. doi: 10.1016/j.rmed.2009.03.005. Epub 2009 Apr 11.

17.

Frequency of self-reported COPD exacerbation and airflow obstruction in five Latin American cities: the Proyecto Latinoamericano de Investigacion en Obstruccion Pulmonar (PLATINO) study.

Montes de Oca M, Tálamo C, Halbert RJ, Perez-Padilla R, Lopez MV, Muiño A, Jardim JRB, Valdivia G, Pertuzé J, Moreno D, Menezes AMB.

Chest. 2009 Jul;136(1):71-78. doi: 10.1378/chest.08-2081. Epub 2009 Apr 6.

PMID:
19349388
18.

Prevalence of sleep related symptoms in four Latin American cities.

Bouscoulet LT, Vázquez-García JC, Muiño A, Márquez M, López MV, de Oca MM, Talamo C, Valdivia G, Pertuze J, Menezes AM, Pérez-Padilla R; PLATINO Group.

J Clin Sleep Med. 2008 Dec 15;4(6):579-85.

19.

Use of respiratory medication in five Latin American cities: The PLATINO study.

Montes de Oca M, Tálamo C, Perez-Padilla R, Lopez MV, Muiño A, Jardim JR, Valdivia G, Pertuzé J, Moreno D, Halbert RJ, Menezes AM; PLATINO Team.

Pulm Pharmacol Ther. 2008 Oct;21(5):788-93. doi: 10.1016/j.pupt.2008.06.003. Epub 2008 Jun 22.

PMID:
18621136
20.

Worldwide burden of COPD in high- and low-income countries. Part II. Burden of chronic obstructive lung disease in Latin America: the PLATINO study.

Menezes AM, Perez-Padilla R, Hallal PC, Jardim JR, Muiño A, Lopez MV, Valdivia G, Pertuze J, Montes de Oca M, Tálamo C; PLATINO Team.

Int J Tuberc Lung Dis. 2008 Jul;12(7):709-12.

PMID:
18544192
21.

[Treatment of chronic obstructive pulmonary disease in 5 Latin American cities: the PLATINO study].

López Varela MV, Muiño A, Pérez Padilla R, Jardim JR, Tálamo C, Montes de Oca M, Valdivia G, Pertuzé J, Halbert R, Menezes AM; PLATINO Group.

Arch Bronconeumol. 2008 Feb;44(2):58-64. Spanish.

22.

Chronic obstructive pulmonary disease and body mass index in five Latin America cities: the PLATINO study.

Montes de Oca M, Tálamo C, Perez-Padilla R, Jardim JR, Muiño A, Lopez MV, Valdivia G, Pertuzé J, Moreno D, Halbert RJ, Menezes AM; PLATINO Team.

Respir Med. 2008 May;102(5):642-50. doi: 10.1016/j.rmed.2007.12.025. Epub 2008 Mar 7.

23.

Peripheral muscle alterations in non-COPD smokers.

Montes de Oca M, Loeb E, Torres SH, De Sanctis J, Hernández N, Tálamo C.

Chest. 2008 Jan;133(1):13-8. doi: 10.1378/chest.07-1592.

PMID:
18187741
24.

[Spirometry reference values after inhalation of 200 microg of salbutamol].

Pérez-Padilla R, Torre Bouscoulet L, Vázquez-García JC, Muiño A, Márquez M, López MV, Montes de Oca M, Tálamo C, Valdivia G, Pertuze J, Jardim J, Menezes AM; grupo PLATINO.

Arch Bronconeumol. 2007 Oct;43(10):530-4. Spanish.

25.

Tuberculosis and airflow obstruction: evidence from the PLATINO study in Latin America.

Menezes AM, Hallal PC, Perez-Padilla R, Jardim JR, Muiño A, Lopez MV, Valdivia G, Montes de Oca M, Talamo C, Pertuze J, Victora CG; Latin American Project for the Investigation of Obstructive Lung Disease (PLATINO) Team.

Eur Respir J. 2007 Dec;30(6):1180-5. Epub 2007 Sep 5.

26.

Impact of bronchodilator use on the prevalence of COPD in population-based samples.

Pérez-Padilla R, Hallal PC, Vázquez-García JC, Muiño A, Máquez M, López MV, de Oca MM, Tálamo C, Valdivia G, Pertuzé J, Jardim J, Menezes AM; PLATINO group.

COPD. 2007 Jun;4(2):113-20.

PMID:
17530504
27.

Diagnostic labeling of COPD in five Latin American cities.

Tálamo C, de Oca MM, Halbert R, Perez-Padilla R, Jardim JR, Muiño A, Lopez MV, Valdivia G, Pertuzé J, Moreno D, Menezes AM; PLATINO team.

Chest. 2007 Jan;131(1):60-7.

PMID:
17218557
28.

The long-term stability of portable spirometers used in a multinational study of the prevalence of chronic obstructive pulmonary disease.

Pérez-Padilla R, Vázquez-García JC, Márquez MN, Jardim JR, Pertuzé J, Lisboa C, Muiño A, López MV, Tálamo C, de Oca MM, Valdivia G, Menezes AM; Latin American COPD Prevalence Study (PLATINO) Team.

Respir Care. 2006 Oct;51(10):1167-71.

29.

[Spirometric reference values in 5 large Latin American cities for subjects aged 40 years or over].

Pérez-Padilla R, Valdivia G, Muiño A, López MV, Márquez MN, Montes de Oca M, Tálamo C, Lisboa C, Pertuzé J, B Jardim JR, B Menezes AM.

Arch Bronconeumol. 2006 Jul;42(7):317-25. Spanish.

30.

Peripheral muscle composition and health status in patients with COPD.

Montes de Oca M, Torres SH, Gonzalez Y, Romero E, Hernández N, Mata A, Tálamo C.

Respir Med. 2006 Oct;100(10):1800-6. Epub 2006 Mar 20.

31.

Prevalence of oxygen desaturation and use of oxygen at home in adults at sea level and at moderate altitude.

Perez-Padilla R, Torre-Bouscoulet L, Muiño A, Marquez MN, Lopez MV, de Oca MM, Talamo C, Menezes AM; Proyecto Latinoamericano de Investigacion en Obstruccion Pulmonar (PLATINO) group.

Eur Respir J. 2006 Mar;27(3):594-9.

32.

Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study.

Menezes AM, Perez-Padilla R, Jardim JR, Muiño A, Lopez MV, Valdivia G, Montes de Oca M, Talamo C, Hallal PC, Victora CG; PLATINO Team.

Lancet. 2005 Nov 26;366(9500):1875-81.

PMID:
16310554
33.

Skeletal muscle inflammation and nitric oxide in patients with COPD.

Montes de Oca M, Torres SH, De Sanctis J, Mata A, Hernández N, Tálamo C.

Eur Respir J. 2005 Sep;26(3):390-7.

34.

[Changes in exercise tolerance, health related quality of life, and peripheral muscle characteristics of chronic obstructive pulmonary disease patients after 6 weeks' training].

Montes de Oca M, Torres SH, González Y, Romero E, Hernández N, Tálamo C.

Arch Bronconeumol. 2005 Aug;41(8):413-8. Spanish.

35.

Electromyographic validation of the mouth pressure-time index: a noninvasive assessment of inspiratory muscle load.

de Torres JP, Talamo C, Aguirre-Jaime A, Rassulo J, Celli B.

Respir Med. 2003 Sep;97(9):1006-13.

36.

[Evaluation of exercise tolerance in patients treated with praziquantel for chronic schistosomiasis with no signs of cardiopulmonary impairment].

Montes de Oca M, Sánchez MA, Tálamo C, de Noya B, López JM.

Arch Bronconeumol. 2003 Sep;39(9):400-4. Spanish. Erratum in: Arch Bronconeumol. 2003 Nov;39(11):534.

37.
38.

Characterization of local memory cells in stage-classified pulmonary tuberculosis: preliminary observations.

Urdaneta E, Feo-Figarella E, Montalvo C, Tálamo C, Castillo Y, Carrasco D, Rivera H, Blanca I, Machado I, Echeverría de Pérez G, De Sanctis JB, Bianco NE.

Scand J Immunol. 1998 May;47(5):496-501.

39.

[With regard to Alcmaeon and Hippocrates].

Talamo C.

Riv Filol Istruz Classica. 1997;125(3):257-62. Italian. No abstract available.

PMID:
17228501
40.

[Liver cirrhosis: pulmonary function].

Marichal I, Dublet P, Medrano G, Hinestrosa H, Tálamo C, Korchoff W, Alvarado R, Quirós E.

G E N. 1991 Oct-Dec;45(4):263-9. Spanish.

PMID:
1843958
41.

Work of breathing in patients with chronic obstructive pulmonary disease in acute respiratory failure.

Fleury B, Murciano D, Talamo C, Aubier M, Pariente R, Milic-Emili J.

Am Rev Respir Dis. 1985 Jun;131(6):822-7.

PMID:
4003930
42.

Effect of carbon dioxide on diaphragmatic function in human beings.

Juan G, Calverley P, Talamo C, Schnader J, Roussos C.

N Engl J Med. 1984 Apr 5;310(14):874-9.

PMID:
6422298
43.

Effects of aminophylline on diaphragmatic fatigue during acute respiratory failure.

Vires N, Aubier M, Murciano D, Fleury B, Talamo C, Pariente R.

Am Rev Respir Dis. 1984 Mar;129(3):396-402.

PMID:
6422814
44.

[Post-phlebitis syndromes. Indications and limitations of surgical treatment].

Mangiola A, Talamo C, Chini L, Maresca A.

Minerva Chir. 1980 Dec 15-31;35(23-24):1951-5. Italian. No abstract available.

PMID:
7290407
45.

[Generalized peritonitis. Diagnostic and therapeutic aspects].

Chini L, Talamo C, Tagliaferro P, Maresca A.

Minerva Chir. 1980 Dec 15-31;35(23-24):1943-9. Italian. No abstract available.

PMID:
7290406
46.

[Massive intra-thyroid hemorrhage in a patient with adenoma].

Tagliaferro P, Talamo C, Chini L, Mangiola A.

Minerva Med. 1980 Jun 8;71(23):1693-700. Italian. No abstract available.

PMID:
7383425
47.

[Our guideline in the treatment of acute cholecystitis].

Maresca A, Talamo C, Mangiola A, Tagliaferro P.

Minerva Med. 1980 Mar 10;71(9):645 50. Italian. No abstract available.

PMID:
7360401

Supplemental Content

Loading ...
Support Center